S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48

A Textbook Reversal For Scotts Miracle-Gro Shareholders

Thursday, November 4, 2021 | Thomas Hughes
A Textbook Reversal For Scotts Miracle-Gro Shareholders

A Classic Entry Signal For Scotts Miracle-Gro 

Scotts Miracle-Gro (NYSE: SMG) reported a double-digit decline in YOY sales but that is the only negative thing we can say about the report. The company beat on all other metrics and indicated strong demand for products would carry through into next year. What investors need to keep in perspective is that the Q4 period is traditionally weak because of seasonal factors and losses are usually expected. Factor in the strong comps during last year’s stay-at-home and home-improvement phases of the pandemic and the 17% decline in sales is nothing. On a full-year basis, the company’s sales are up double-digits and on top of last year’s 25% increase. The takeaway for investors new and prospective alike is that results were so strong they are confirming a classic reversal in share prices of the stock. 

“The continued engagement by consumers throughout the lawn and garden season drove full-year U.S. Consumer sales 11 percent higher on a full-year basis on top of last year’s 25 percent growth,” said Jim Hagedorn, chairman, and chief executive officer. “Consumer purchases of our products at our largest retail partners – as measured in units – were up 6 percent for the full year, with growth in every major product category. When compared

to 2019, consumer purchases are up 21 percent and suggest a level of consumer enthusiasm that we expect to carry into the 2022 lawn and garden season.”

A Strong Quarter For Scotts Miracle-Gro 

Scotts Miracle-Gro produced revenue of $737.8 million in the fiscal 4th quarter or down 17.1% from last year. The 17.1% decline isn’t pretty to see but is against last year’s comp of up 79% so still a strong figure in terms of revenue. On a two-year basis, the revenue is up 48% which is an equally strong figure for investors to chew on. The best news is that revenue beat the Marketbeat.com consensus by 600 basis points and reveals the stickiness of trends sparked by the pandemic. On a segment basis, the consumer segment fell 28% YOY but is up 11% for the year while the Hawthorne segment fell a smaller 2.0% for the quarter and is still up 39% for the year. 

Moving down the report, the company did experience some margin pressures but has plans to mitigate that in the first quarter of the year. Gross margins shrank nearly 700 basis points under the influence of higher costs for commodities, freight, and labor but were offset to some degree by decreased promotional activity and price increases. The good news is that higher costs were not enough to completely offset the revenue strength and the company is planning to raise prices again. On the bottom line, the company’s GAAP loss (seasonally expected) came in at $0.87 and beat the consensus by $0.02 while the adjusted loss of $0.84 beat by $0.04. 

Turning to the guidance, the company is expecting demand to hold up over the next year and possibly grow. Revenue is expected in the range of up 0% to 3% and we see upside risk in the numbers. As for earnings, the company is expecting adjusted EPS in the range of $8.50 to $8.90 compared to the Marketbeat.com consensus of $8.54. 

New Repurchase Plan Helps Lift Scotts Miracle-Gro 

Scotts Miracle-Gro took on quite a bit of debt with the acquisition of Hawthorne but that effort has been paying off. While net debt is still high in relation to cash, cash flow, and free cash flow all metrics are improved to the point execs have decided to begin repurchasing shares. The new allotment is worth $300 million or about 3.6% of the market cap and will begin in the first quarter of the year. 

Turning to the charts, shares of Scotts Miracle-Gro are up more than 12% on the news and look ready to move higher. Not only is price action confirming support at the short-term moving average but the indicators are firing strong entry signals as well. With such a strong set-up in play, we expect to see this stock continue moving in the near, mid, and long terms with periodic sell-offs that should be viewed as buying opportunities. 

Should you invest $1,000 in Scotts Miracle-Gro right now?

Before you consider Scotts Miracle-Gro, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Scotts Miracle-Gro wasn't on the list.

While Scotts Miracle-Gro currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Scotts Miracle-Gro (SMG)3.2$161.27+0.3%1.64%18.04Buy$213.13
Compare These Stocks  Add These Stocks to My Watchlist 


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.